Live news related to NFL BIOSCIENCES stock (FR0014003XT0): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on NFL BIOSCIENCES mainly cover M&A activity. The stock trades at €0,46 on Euronext Paris, up 14,34% at the last update. This page lists the articles published on NFL BIOSCIENCES stock to track the share price, company announcements and any item likely to influence market perception.
NFL Biosciences announced on October 30, 2026 that its entire management team will take part in BIO-Europe 2026, held from November 9 to 11 in Cologne…
NFL Biosciences published half-year accounts on October 22, 2026, marking the transition from a preparation phase to a clinical execution phase. The b…
NFL Biosciences announced on October 22, 2026, that it has obtained authorizations from the ANSM and the Committee for the Protection of Persons (CPP)…
NFL Biosciences provided an update on October 6, 2026 on its two smoking cessation candidates, NFL-101 and NFL-102. The company detailed the timeline …
NFL Biosciences announced on September 8, 2026 that its work on a predictive biomarker related to NFL-101 efficacy has been selected for oral presenta…
NFL Biosciences announced on July 7, 2026, that three scientific communications dedicated to its drug candidates NFL-101 and NFL-102 have been accepte…
NFL Biosciences announces the successful manufacturing of a clinical batch of NFL-102, its anti-smoking drug candidate, and the full validation of its…
On Monday, NFL Biosciences released analysis results of its drug candidate NFL-101 conducted in a sub-population defined by a predictive biomarker. Th…
